-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Virpax Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2021 to Q3 2024.
- Virpax Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was -$17.7K, a 109% decline year-over-year.
- Virpax Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $118K, a 83% decline year-over-year.
- Virpax Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $545K, a 26.9% decline from 2022.
- Virpax Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $745K, a 23.5% decline from 2021.
- Virpax Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $974K, a 33.9% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)